Last reviewed · How we verify
Intra-articular Tocilizumab — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intra-articular Tocilizumab (Intra-articular Tocilizumab) — Chinese PLA General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intra-articular Tocilizumab TARGET | Intra-articular Tocilizumab | Chinese PLA General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intra-articular Tocilizumab CI watch — RSS
- Intra-articular Tocilizumab CI watch — Atom
- Intra-articular Tocilizumab CI watch — JSON
- Intra-articular Tocilizumab alone — RSS
Cite this brief
Drug Landscape (2026). Intra-articular Tocilizumab — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-articular-tocilizumab. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab